PG
NVO

PEAK6 Group’s Novo Nordisk NVO Stock Holding History

PEAK6 Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-19,544
Closed -$464K – 4761
2018
Q1 		$481K Sell
19,544
-8,044
-29% -$211K ﹤0.01% 2611
2017
Q4 		$740K Sell
27,588
-7,894
-22% -$201K ﹤0.01% 2157
2017
Q3 		$854K Buy
+35,482
New +$802K ﹤0.01% 2101
2017
Q2 		– Sell
-1,410
Closed -$28.5K – 4856
2017
Q1 		$24K Buy
+1,410
New +$24.6K ﹤0.01% 4017
2016
Q2 		– Sell
-81,828
Closed -$2.24M – 4620
2016
Q1 		$2.22M Buy
+81,828
New +$2.19M 0.02% 1096
2015
Q2 		– Sell
-45,846
Closed -$1.29M – 5333
2015
Q1 		$1.22M Buy
+45,846
New +$1.06M 0.01% 1685
2013
Q3 		– Sell
-43,000
Closed -$723K – 5355
2013
Q2 		$666 Buy
+43,000
New +$716K ﹤0.01% 2512

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

PEAK6 Group's NVO Position: Q2 2018 in Review

PEAK6 Group sold out of Novo Nordisk (NVO) in Q2 2018, closing a stake of 19,544 shares — an estimated $464K sold.

PEAK6 Group first reported a position in NVO in Q2 2013 and held it in 7 quarters. The position peaked at $2.22M in Q1 2016. 537 funds tracked by Wall St. Rank hold NVO as of Q2 2018.

  • PEAK6 Group reported no remaining Novo Nordisk position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 19,544 Novo Nordisk shares in Q2 2018, an estimated $464K.
  • PEAK6 Group first reported a position in Novo Nordisk in Q2 2013 and held it in 7 quarters.
  • PEAK6 Group's Novo Nordisk position peaked at $2.22M in Q1 2016.
  • 537 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.